Literature DB >> 18505722

Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.

Albert G Remacle1, Sergey A Shiryaev, Eok-Soo Oh, Piotr Cieplak, Anupama Srinivasan, Ge Wei, Robert C Liddington, Boris I Ratnikov, Amelie Parent, Roxane Desjardins, Robert Day, Jeffrey W Smith, Michal Lebl, Alex Y Strongin.   

Abstract

We present the data and the technology, a combination of which allows us to determine the identity of proprotein convertases (PCs) related to the processing of specific protein targets including viral and bacterial pathogens. Our results, which support and extend the data of other laboratories, are required for the design of effective inhibitors of PCs because, in general, an inhibitor design starts with a specific substrate. Seven proteinases of the human PC family cleave the multibasic motifs R-X-(R/K/X)-R downward arrow and, as a result, transform proproteins, including those from pathogens, into biologically active proteins and peptides. The precise cleavage preferences of PCs have not been known in sufficient detail; hence we were unable to determine the relative importance of the individual PCs in infectious diseases, thus making the design of specific inhibitors exceedingly difficult. To determine the cleavage preferences of PCs in more detail, we evaluated the relative efficiency of furin, PC2, PC4, PC5/6, PC7, and PACE4 in cleaving over 100 decapeptide sequences representing the R-X-(R/K/X)-R downward arrow motifs of human, bacterial, and viral proteins. Our computer analysis of the data and the follow-on cleavage analysis of the selected full-length proteins corroborated our initial results thus allowing us to determine the cleavage preferences of the PCs and to suggest which PCs are promising drug targets in infectious diseases. Our results also suggest that pathogens, including anthrax PA83 and the avian influenza A H5N1 (bird flu) hemagglutinin precursor, evolved to be as sensitive to PC proteolysis as the most sensitive normal human proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505722      PMCID: PMC2475709          DOI: 10.1074/jbc.M803762200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  A method for rapid protease substrate evaluation and optimization.

Authors:  Igor A Kozlov; Peter C Melnyk; Chanfeng Zhao; John P Hachmann; Veronika Shevchenko; Anu Srinivasan; David L Barker; Michal Lebl
Journal:  Comb Chem High Throughput Screen       Date:  2006-07       Impact factor: 1.339

3.  Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.

Authors:  Sergey A Shiryaev; Boris I Ratnikov; Alexander E Aleshin; Igor A Kozlov; Nicholas A Nelson; Michal Lebl; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Alternative to piperidine in Fmoc solid-phase synthesis.

Authors:  John Hachmann; Michal Lebl
Journal:  J Comb Chem       Date:  2006 Mar-Apr

Review 5.  Proprotein convertases: lessons from knockouts.

Authors:  Nathalie Scamuffa; Fabien Calvo; Michel Chrétien; Nabil G Seidah; Abdel-Majid Khatib
Journal:  FASEB J       Date:  2006-10       Impact factor: 5.191

Review 6.  The pathogenesis of influenza in humans.

Authors:  M C Zambon
Journal:  Rev Med Virol       Date:  2001 Jul-Aug       Impact factor: 6.989

7.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

8.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine.

Authors:  Guan-Sheng Jiao; Lynne Cregar; Jinzhi Wang; Sherri Z Millis; Cho Tang; Sean O'Malley; Alan T Johnson; Sina Sareth; Jason Larson; Gary Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

Review 9.  Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.

Authors:  Philipp Stawowy; Eckart Fleck
Journal:  J Mol Med (Berl)       Date:  2005-10-22       Impact factor: 4.599

10.  Search for optimal coupling reagent in multiple peptide synthesizer.

Authors:  John Hachmann; Michal Lebl
Journal:  Biopolymers       Date:  2006       Impact factor: 2.505

View more
  59 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

3.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

4.  Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen.

Authors:  Geoffrey K Feld; Alexander F Kintzer; Iok I Tang; Katie L Thoren; Bryan A Krantz
Journal:  J Mol Biol       Date:  2011-10-31       Impact factor: 5.469

5.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

6.  Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.

Authors:  Sergey A Shiryaev; Piotr Cieplak; Alexander E Aleshin; Qing Sun; Wenhong Zhu; Khatereh Motamedchaboki; Alexander Sloutsky; Alex Y Strongin
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

Review 7.  Processing of peptide and hormone precursors at the dibasic cleavage sites.

Authors:  Mohamed Rholam; Christine Fahy
Journal:  Cell Mol Life Sci       Date:  2009-03-20       Impact factor: 9.261

8.  Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor β1a (TGFβ1a).

Authors:  Hannu Turpeinen; Anna Oksanen; Virpi Kivinen; Sampo Kukkurainen; Annemari Uusimäki; Mika Rämet; Mataleena Parikka; Vesa P Hytönen; Matti Nykter; Marko Pesu
Journal:  J Biol Chem       Date:  2013-10-31       Impact factor: 5.157

9.  Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.

Authors:  Alberto J López-Jiménez; Trayambak Basak; Roberto M Vanacore
Journal:  J Biol Chem       Date:  2017-09-01       Impact factor: 5.157

10.  Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P).

Authors:  Dominique J Burri; Joel Ramos da Palma; Nabil G Seidah; Giuseppe Zanotti; Laura Cendron; Antonella Pasquato; Stefan Kunz
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.